Announcement on Subsidiary Obtaining Drug Registration Certificate and Notice of Approval for Marketing Application of API

About this update from Shanghai Haixin Group Co., Ltd. Class A

Announcement on the Subsidiary Obtaining Drug Registration Certificate and Notice of Approval for Marketing Application of APIThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Haixin Group Co., Ltd. Class A